Insider trades
Daniel Janney, Director of Krystal Biotech KRYS, has filed 0 purchases and 34 sales on the open market. Over the past 12 months that comes to a net sale of $19.4M. The latest trade was on 02/27.
Daniel Janney
Director
- Company
- Krystal Biotech KRYS
- First filing
- 23/05/30
- Trades
- 40 trades
- Buys / sales
- 0 / 34
- 12-month net buying
- −$19.4M
- Last trade
- 02/27
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 02/27 | 03/03 | 11,803 sh2 trades | $275.59avg. | $3,252,844.91 | −13.9% | |
| Open-market sale10b5-1 plan | 02/24–02/26 | 02/26 | 60,161 sh20 trades | $268.44avg. | $16,149,459.41 | No record | |
| Open-market sale | 23/06/08–23/06/09 | 23/06/09 | 50,000 sh9 trades | $128.36avg. | $6,418,119.69 | −31.8% | |
Krystal BiotechKRYS | Open-market sale10b5-1 plan | 23/05/19 | 23/05/23 | 50,000 sh | $95.02 | $4,751,000 | −24.1% |
Krystal BiotechKRYS | Open-market sale10b5-1 plan | 23/05/09 | 23/05/11 | 17,100 sh | $90.74 | $1,551,654 | −7.6% |
Krystal BiotechKRYS | Open-market sale10b5-1 plan | 23/04/19 | 23/04/21 | 7,900 sh | $90.32 | $713,528 | −3.4% |